Accurate, visionary, and thought-provoking insight into issues that impact your business.
October 23, 2024 Prior authorizations are notorious for reducing access to care by complex approval cycles, but the right tech can help overcome.
October 21, 2024 Insurance broker Baldwin Group is working with Persistent to fastcharge its GenAI adoption.
October 15, 2024 Value-based care is a insurance construct being force fitted into care delivery that 60 years of experimentation has shown, it does not work. It is time to move
September 27, 2024 Health plans continue to escalate their costs while diluting the value proposition; employers must replace health plans and start a new alternate journey.
September 18, 2024 The outcomes delivered by 6 of US’s largest healthcare companies are terrible and they need to account for it.
September 16, 2024 The term "supply chain" is a misnomer that no longer reflects the multi-tiered and interconnected reality of 2024 supply networks.
August 1, 2024 The idea that cost reductions related to operations, administration, drugs, etc. will decrease the overall cost of care is false.
July 23, 2024 How new-gen leaders in GBS are pulling away from the pack.
July 22, 2024 There is a major misalignment between healthcare provider priorities and what they seek sourcing for and needs to be addressed urgently.
July 10, 2024 Under adoption of ops-tech by primary care and rehab is limiting their ability to address the needs of their patients.
June 27, 2024 Hitachi and Jacobs Solutions Inc. are transforming water management practices with AIenabled solutions.
June 21, 2024 Efforts to limit medical debt in credit reporting will not address people hurting and the greed intrinsic to our healthcare system.
If you don't have an account, Register here |
With the exception of our Horizons reports, most of our research is available for free on our website. Sign up for a free account and start realizing the power of insights now.
Our premium subscription gives enterprise clients access to our complete library of proprietary research, direct access to our industry analysts, and other benefits.
Contact us at [email protected] for more information on premium access.
